Steven Check’s Cardlytics CDLX Stock Holding History

Steven Check’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,450	Closed	-$123K	–	51
2025 Q2	$123K	Buy	7,450 +1,280	+21%	+$22.1K	﹤0.01%	49
2025 Q1	$112K	Buy	6,170 +550	+10%	+$15.7K	﹤0.01%	50
2024 Q4	$209K	Buy	5,620 +555	+11%	+$21.2K	0.01%	48
2024 Q3	$162K	Buy	5,065 +477	+10%	+$26.5K	0.01%	49
2024 Q2	$377K	Buy	4,588 +340	+8%	+$36.8K	0.01%	33
2024 Q1	$615K	Buy	4,248 +1,928	+83%	+$163K	0.02%	26
2023 Q4	$214K	Buy	2,320 +285	+14%	+$29K	0.01%	43
2023 Q3	$336K	Buy	2,035 +845	+71%	+$110K	0.01%	33
2023 Q2	$75.2K	Buy	1,190 +110	+10%	+$6.66K	﹤0.01%	39
2023 Q1	$36.7K	Buy	1,080 +20	+2%	+$1.04K	﹤0.01%	39
2022 Q4	$61.3K	Buy	1,060 +12	+1%	+$741	﹤0.01%	38
2022 Q3	$99K	Buy	+1,048	New	+$149K	0.01%	37
2022 Q2	–	Sell	-656	Closed	-$360K	–	43
2022 Q1	$360K	Buy	+656	New	+$396K	0.01%	35

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Steven Check's CDLX Position: Q3 2025 in Review

Steven Check sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 7,450 shares — an estimated $123K sold.

Steven Check first reported a position in CDLX in Q1 2022 and held it in 13 quarters. The position peaked at $615K in Q1 2024. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

Steven Check reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
Steven Check sold 7,450 Cardlytics shares in Q3 2025, an estimated $123K.
Steven Check first reported a position in Cardlytics in Q1 2022 and held it in 13 quarters.
Steven Check's Cardlytics position peaked at $615K in Q1 2024.
81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Check Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.